Pulmonary Complications of Hematopoietic Stem Cell Transplantation

Completed

Conditions studied: Lung Disease

In brief

The purpose of this study is to determine risk factors associated with the development of lung disease after hematopoietic stem cell transplantation. Depending on the results and findings of this study, it may be possible to predict who is at higher risk of serious complications and ultimately develop therapies to prevent or treat this lung disease.

Key facts

Study ID

NCT00837681

Run by

Karen Wood

People needed

350

Starts

2005-10-01

Expected to finish

2016-07-08

Last updated by the study team

2017-02-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• All patients scheduled to undergo hematopoietic stem cell transplantation (HSCT)

You may not qualify if…

• Patients whose ability to give informed consent is in question.
• Pregnancy.

Where it is running

• The Ohio State University — Columbus, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.